Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$24,000.00

Gut host-microbiome-pathogen interaction: understanding the pathophysiology of bacterial infections

EF 2024-25

Résumé
The intestinal tract is a unique organ system. Beyond its key functions of digestion and absorption of nutrients, it harbours a rich and diverse microbiota. In pork production, intestinal infections are a major barrier to optimal animal performance and to the industry economic competitiveness. The host-microbiome-pathogen interactions that takes place in the intestines play a role in both healthy and diseased states. Swine dysentery (SD), characterized by mucoid and bloody diarrhea, is a current challenge in the swine industry. There are no vaccines available, leaving antibiotics as the only way to treat and control the disease. It is caused by the spirochete Brachyspira hyodysenteriae, and during outbreaks up to 100% of a herd can be affected. Despite almost 100 years since SD was first described, we do still not understand how lesions develop. Here we propose to define the mechanisms that lead to SD, and to provide the basis for infection control and prevention strategies. We have previously shown that Brachyspira infection leads to high levels of nitric oxide (NO) by-products in the colon. NO stimulates vasodilation, mucus and chloride secretion in the intestine, all of which contribute to the hallmark clinical sign of SD: bloody diarrhea. Objective 1 will characterize the role and source of NO during the development of colitis and bloody diarrhea. We will employ our in vitro colon culture model, in combination with spatial gene expression and histology techniques, to understand how NO contributes to SD. Next, we will explore how an NO-inhibitor can be applied to prevent clinical signs. Objective 2 will investigate the ability of a novel Brachyspira bacteriocin to select the microbiota in the colon. Others have shown that pigs without a microbiota do not develop the clinical signs of SD. We will use a combination of in vitro and animal trials, molecular imaging and high-throughput sequencing, to clarify how the pathogen actively modulates the colon microbiome in its advantage, culminating in severe disease. Objective 3 will profile the immunosuppressive strategies employed by Brachyspira to avoid the host defences. Using immune cells isolated from the colon, we will explore how the pathogen supresses the initial immune response by profiling the transcriptome of these cells. This objective will shed a light on why previous vaccine development efforts have failed, and help future improvements. In the current post-antibiotic era, in face of multi-drug resistant bacteria, novel alternatives to control intestinal bacterial infections are needed. The work proposed here will clarify the mechanisms through which the host-microbiome-pathogen triad interact, and how we can leverage this knowledge to develop new strategies that mitigate disease, while not contributing to antimicrobial resistance.
Programme
Discovery Grants Program - Individual
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2020-06353
Name nom
Costa, Matheus
Department département
Large Animal Clinical Sciences
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Gut host-microbiome-pathogen interaction: understanding the pathophysiology of bacterial infections
Keywords
pathophysiology; bacterial infection; colitis; mechanism of intestinal infection; bacterial pathogenesis; host-microbiome-pathogen; host-pathogen interactions
Application summary
The intestinal tract is a unique organ system. Beyond its key functions of digestion and absorption of nutrients, it harbours a rich and diverse microbiota. In pork production, intestinal infections are a major barrier to optimal animal performance and to the industry economic competitiveness. The host-microbiome-pathogen interactions that takes place in the intestines play a role in both healthy and diseased states. Swine dysentery (SD), characterized by mucoid and bloody diarrhea, is a current challenge in the swine industry. There are no vaccines available, leaving antibiotics as the only way to treat and control the disease. It is caused by the spirochete Brachyspira hyodysenteriae, and during outbreaks up to 100% of a herd can be affected. Despite almost 100 years since SD was first described, we do still not understand how lesions develop. Here we propose to define the mechanisms that lead to SD, and to provide the basis for infection control and prevention strategies. We have previously shown that Brachyspira infection leads to high levels of nitric oxide (NO) by-products in the colon. NO stimulates vasodilation, mucus and chloride secretion in the intestine, all of which contribute to the hallmark clinical sign of SD: bloody diarrhea. Objective 1 will characterize the role and source of NO during the development of colitis and bloody diarrhea. We will employ our in vitro colon culture model, in combination with spatial gene expression and histology techniques, to understand how NO contributes to SD. Next, we will explore how an NO-inhibitor can be applied to prevent clinical signs. Objective 2 will investigate the ability of a novel Brachyspira bacteriocin to select the microbiota in the colon. Others have shown that pigs without a microbiota do not develop the clinical signs of SD. We will use a combination of in vitro and animal trials, molecular imaging and high-throughput sequencing, to clarify how the pathogen actively modulates the colon microbiome in its advantage, culminating in severe disease. Objective 3 will profile the immunosuppressive strategies employed by Brachyspira to avoid the host defences. Using immune cells isolated from the colon, we will explore how the pathogen supresses the initial immune response by profiling the transcriptome of these cells. This objective will shed a light on why previous vaccine development efforts have failed, and help future improvements. In the current post-antibiotic era, in face of multi-drug resistant bacteria, novel alternatives to control intestinal bacterial infections are needed. The work proposed here will clarify the mechanisms through which the host-microbiome-pathogen triad interact, and how we can leverage this knowledge to develop new strategies that mitigate disease, while not contributing to antimicrobial resistance.